Arginine esterase activity in chloroform-ellagic acid-treated plasma from 11 patients with cystic fibrosis (CF) and 12 age-matched control subjects has been resolved into its component fractions by ion exchange chromatography on DEAE-Sephadex and electrofocusing on polyacrylamide gels. The activity can be resolved into two fractions by chromatography, one of which is inhibited by soybean trypsin inhibitor (STI) and the other of which is not inhibited by STI. In plasma of CF patients, the fraction of activity inhibited by ST1 is reduced to approximately 30y0 of the corresponding fraction in control plasma. In contrast, the fraction of activity resistant to inhibition by ST1 did not show any significant quantitative differences between control and CF plasma samples.
Introduction
Cystic fibrosis (CF) i s an autosomal recessive disorder in which the basic defect remains unknown. Numerous theories including alterations in ion transport, glycoprotein structure and membrane permeability (5. 6 , have been proposed. It has been postulated that a unified theory of pathogenesis of CF will emerge from some of the approaches currently being taken (5).
It has been observed by several investigators that saliva (I1) and serum (1.14) of these patients contain "factors" which appear to be characteristic of the disease. The "factor" in saliva inhihits sodium reabsorption in r a t parotid glands (11). The "factor" in serum induces dyskinesis in ciliary preparations from rabbit trachea (I4) and oyster gills (1).
The "factors" in saliva and serum a r e nondialyzable, have a net positive charge at neutral pH, a r e inactive in the presence of negatively charged polymers such a s heparin and contain protein moieties. We have postulated (12) that the presence of these "factors" is due to the deficiency of enzymic activity similar to trypsin. Accordingly, we have shown that saliva and lasma of patients with C F a r e deficient in arginine esterase activity (12, f3).
We have also postulated (13) that one of the several types of the arginine esterases might be totally absent in plasma of patients with CF. The present study demonstrates qualitative andquantitative differences in arginine esterase activity in plasma and fractions of plasma from controls and patlents with CF.
Materials and Methods
Blood samples were collected from 11 patients with CF and 12 agematched controls after obtaining informed consent. 9.0 ml blood was mixed with 1.0 ml of 3.8% sodium citrate in plastic tubes. The plasma was separated by centrifugation a t 40 C and the samples were used immediately o r stored at -70° C until use. All samples were handled either in plasticware o r siliconized glassware. Plasma was treated with chloroform-ellagic acid (2) a t 24O C for 15 mins and transferred to an ice bath.
The ellagic acid activated plasma was analyzed by chromatography on DEAE-Sephadex columns a t pH 8.0 and by electrofocusing on polyacrylamide gels. The sample for chromatography was prepared a s follows. 6.0 ml of activated plasma was chilled to 4O C in an ice bath and solid ammonium sulfate was added under stirring to 25% saturation. After 15 mins it was centrifuged and the precipitate discarded. Solid dpmonium sulfate was added to the supernatant to 50% saturation, and centrifuged a t 30,000 x g for 15 mins a t 4O C. The precipitate was dissolved in a small volume of w i~e r and desalted on a column of Sephadex G-50 equilibrated with 5 mM phoqphate buffer, pH 8.0. The desarted samples were used for chromatographic analysis. Another aliquot (1.0 ml) of the ellagic acid activated plksma was passed through a Sephadex G-50 column equilibrated with 5 mM pQosphate buffer, pH 8.0. The Sephadex eluate was used in polyacrylamide gel electrofocusing analyses.
which is almost totally resistant to inhibition by STI. This pattern of distribution of activities was consistently observed in all plasma samples from controls. The pattern of elution of arginine esterase activity from plasma samples of patients with CF is shown in Figure 1B . A reduction of approximately 60-75% of the size peak I was found in plasma of all CF patients tested. The size of peak I1 was similar to that observed in controls.
Electrofocusing on polyacrylamide gels and subsequent staining for arginine esterase activity revealed seven bands in plasma samples from all controls (Figure 2) . Six of these bands, designated A-F, represent arginine esterase activity, while the band X is an artifact produced by the contact of sulfuric acid with the gel. A cluster of three bands called C, D, and E were observed a t the center of the gel. These three bands a r e the most intense among the six bands. In plasma samples from all 11 patients with CF, only five arginine esterase bands were found. In 8 samples, band D was missing; in 2, band E was missing; and in 1 sample, band C was missing. These patterns were reproducible with all the plasma samples tested. Freezing and thawing of plasma, a t least three times, did not alter the qualitative pattern of separation either in plasma from controls o r from patients with CF. Electrofocusing of fraction 1 from DEAE-Sephadex columns revealed patterns of arginine esterase activity similar to whole plasma in both controls and patients with CF: the band missing in the DEAE-Sephadex column fraction from patients with CF corresponded to the band missing in the whole activated plasma from which i t was derived. Plasma samples from 5 obligate heterozygotes showed patterns similar to plasma from controls.
Discussion
These data confirm and extend our previous observation of a defici2ncy of arginine esterase activity in saliva and plasma of patients with CF. Electrofocusing experiments on polyacrylamide gels further delineate the quantitative deficiency of arginine esterase activity to the absence of a single type of arginine esterase. In all CF cases studied, a single band of arginine esterase activity was absent. In the majority of patients, a specific band was missing; however, in some patients, a different band in the same narrow pH range of the gel was absent. This finding can be interpreted in a number of ways. One possibility is that of genetic heterogeneity. The possibility that CF may not be a single entity but rather a group of closely related genetic abnormalities with similar pathological consequences has been discussed by many authors (3.4.5).
Studies of individual families should clarify the uniqueness of the qualitative differences reported in this preliminary communication. Another possibility is that the absence of different bands in a narrow pH zone could reflect aggregation o r disaggregation of these enzymes. Further studies a r e needed to clarify these points. Studies of arginine esterase activity in different organs o r cells of patients with cystic fibrosis should shed light on the specificity of our observation.
No significant loss of arginine esterase activity was observed during
These findings a r e consistent with the hypothesis that a specific the preparation of samples for chromatography or electrofocusing. enzyme, in this case an arginine esterase, may be responsible for the numerous biochemical abnormalities which have been found in this disease. Chromatography of the Sephadex G-50 eluate of the ammonium sulfate precipitate was performed on DEAE-Sephadex columns equilibrated with 5 mM phosphate buffer, pH 8.0, essentially according to Colman & (2) but using a NaCl gradient between 0.0 -0.3 M NaC1. Arginine esterase activity of samples and fractions from Sephadex columns were assayed spectrophotometrically a t 253 nm using 6-N-benzoyl-L-areinine ethvl Hirschhorn (lo) has suggested that the anticiliary factor in serum of C F patients i s a complex of the C-3a component of the complement system with immunoglobulin. In the normal individual, the arginine esterase could inactivate the complement. In the case of the C F patient, absence of the arginine esterase enzyme would result in the accumulation of the complex and would in some a s yet undefined manner produce the clinical manifest- by a standard method 6). 5% polyacrylamide gels containing 0.75% ampholine (pH range of 5-8) were made using 0.044% ammonium persulfate a s the catalyst. The length of the gel was 72 mm. The gel was supported a t the bottom by a layer of cheese cloth. 0.75% ampboline in water was layered to a height of 26 mm over the top of the gel surface. The tubes were mounted in a disc gel electrophoresis apparatus. The anode compartment contained 0.2% of H2SO4 and the cathode compartment contained 0.4% diethanolamine. The gel was pre-run a t 200 v a t 4O C for 1 h r by which time the current fell to a steady value. Ammonium persulfate was removed from the gel by this pre-run.
Summary
Arginine esterase activity has been shown to be quantitatively and qualitatively different in plasma of patients with CF when compared to agematched controls. This activity is significantly reduced in a specific eluate of plasma from C F patients when resolved by DEAE-Sephadex chromatography. In addition, qualitative alteration of arginine esterase activity, consisting of an absence of a single band of activity, has been found in plasma of patients with CF when studied by electrofocusing in polyacrylamide gels. Although the plasma of the majority of patients exhibited the absence of a specific arginine esterase activity band, a number yielded deficiencies in other single bands within the same narrow pH region. These observations After the pre-run, a mixture of 0.050 ml of Sephadex eluate of the a r e consistent with the concept of genetic heterogeneity of the disease. activated plasma and 0.050 ml of 40% sucrose (w/v) was introduced under the layer of ampholine. Electrofocusing was continued a t 2M) v for 12 hrs a t 4O C. The gels were stained for areinine esterase activitv a t 370 C 
